Filing Details

Accession Number:
0001127602-17-012624
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-03-22 16:20:31
Reporting Period:
2017-03-21
Filing Date:
2017-03-22
Accepted Time:
2017-03-22 16:20:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
64803 Cvs Health Corp CVS Retail-Drug Stores And Proprietary Stores (5912) 050494040
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1351402 A Troyen Brennan One Cvs Drive
Woonsocket RI 02895
Evp And Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-03-21 16,637 $45.07 94,309 No 4 M Direct
Common Stock Disposition 2017-03-21 16,637 $78.73 77,672 No 4 S Direct
Common Stock Disposition 2017-03-21 7,212 $78.73 70,460 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option Disposition 2017-03-21 16,637 $0.00 16,637 $45.07
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2013-04-02 2019-04-02 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock (Restricted) 36,572 Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option $54.53 2014-04-01 2020-04-01 23,604 23,604 Direct
Common Stock Stock Option $74.29 2015-04-01 2021-04-01 54,550 54,550 Direct
Common Stock Stock Option $102.26 2016-04-01 2022-04-01 47,937 47,937 Direct
Common Stock Stock Option $104.82 2017-04-01 2023-04-01 53,772 53,772 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2020-04-01 23,604 23,604 Direct
2021-04-01 54,550 54,550 Direct
2022-04-01 47,937 47,937 Direct
2023-04-01 53,772 53,772 Direct
Footnotes
  1. All sales were effected pursuant to a Rule 10b5-1 plan.
  2. Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $78.30 and $79.00 per share.
  3. Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $78.32 and $79.00 per share.
  4. Option became exercisable in four equal annual installments, commencing 4/2/2013.
  5. Option became exercisable in four equal annual installments, commencing 4/1/2014.
  6. Option became exercisable in four equal annual installments, commencing 4/1/2015.
  7. Option became exercisable in four equal annual installments, commencing 4/1/2016.
  8. Option becomes exercisable in four equal annual installments, commencing 4/1/2017.